Funding for this research was provided by:
National Institute on Aging (1RF1AG059407, AG066519)
National Center for Advancing Translational Sciences (UL1 TR001414)
National Science Foundation (DGE-183928)
Received: 25 October 2020
Accepted: 23 December 2020
First Online: 8 January 2021
Ethics approval and consent to participate
: This study used deidentified patient data and did not require ethics approval.
: Not applicable
: JDG reports research support from Biogen, Eli Lilly, Genentech, the Alzheimer’s Disease Cooperative Study, and the Alzheimer’s Clinical Trial Consortium. He has no other competing interests.